- Germline genetic variation and treatment response on CCG-1891Dana M Sepe
The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 4318, USA
Pediatr Blood Cancer 58:695-700. 2012..We sought to extend current knowledge by using standard and novel statistical methodology to examine polymorphic variants of genes and relapse risk, toxicity, and drug dose delivery in standard risk ALL...
- Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems databaseDana M Walker
Division of Oncology, The Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Pediatr Blood Cancer 60:616-20. 2013....
- Dexrazoxane as a cardioprotectant in children receiving anthracyclinesDana M Sepe
Division of Oncology, The Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Oncologist 15:1220-6. 2010..Continued follow-up from previous trials is needed to determine the long-term effect of dexrazoxane on cardiac outcomes and quality of life...